Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/6/2026

Guideline for Management of Sudden Sensorineural Hearing Loss (AAO‑HNS)

Initial Evaluation

  • Perform Weber and Rinne tuning‑fork tests immediately to distinguish sensorineural from conductive hearing loss, a step that determines the subsequent management pathway. 1
  • Obtain formal audiometry within 24–48 hours (no later than 14 days) to confirm sensorineural loss, defined as a ≥30 dB decrease at three consecutive frequencies occurring within 72 hours. 2
  • Screen for red‑flag features that warrant alternative work‑up: bilateral hearing loss, recurrent or fluctuating episodes, focal neurologic signs (weakness, dysarthria, ataxia, diplopia), severe headache, or concurrent vestibular symptoms. 3

Immediate Medical Treatment

  • Initiate oral prednisone at 1 mg/kg/day (maximum 60 mg) as a single daily dose for 7–14 days followed by a taper; each day of delay worsens prognosis. 1
  • Inform patients that spontaneous recovery occurs in 32–65 % of cases, but corticosteroid therapy improves outcomes; the underlying etiology remains unknown in 85–90 % of presentations. 4

Imaging and Ancillary Work‑up

  • Order MRI of the brain with internal auditory canal gadolinium sequences to evaluate for vestibular schwannoma and other retro‑cochlear pathology. 1
  • If MRI is contraindicated, obtain a temporal‑bone CT or auditory brainstem response (ABR) testing as acceptable alternatives. 4
  • Do not order routine head CT scans for evaluation of sudden sensorineural hearing loss, as they provide no diagnostic benefit. 2
  • Do not obtain routine laboratory tests in idiopathic cases, given the lack of demonstrated benefit. 2

Salvage Therapy for Incomplete Recovery

  • For patients with incomplete hearing recovery 2–6 weeks after initial oral steroids, offer intratympanic dexamethasone (4–6 injections over 2 weeks). 1
  • Hyperbaric oxygen therapy may be considered only when combined with corticosteroids, initiated within 2 weeks of symptom onset for primary treatment or within 1 month for salvage therapy; limited availability and cost restrict its routine use. 1

Treatments to Avoid

  • Routine use of antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants is not recommended due to insufficient supporting evidence. 4

Follow‑up and Rehabilitation

  • Perform audiometric assessment at the end of treatment and repeat within 6 months to document final hearing status. 5
  • The majority of hearing recovery occurs within 1 month (≈ 90 % of final levels), with ≈ 98 % achieving stable hearing by 3 months. 5
  • Counsel all patients with residual loss or persistent tinnitus about hearing aids, assistive listening devices, and formal audiologic rehabilitation; initiate these discussions early to provide immediate benefit and reduce anxiety. 5
  • Schedule at least annual audiometric monitoring for adults to assess hearing stability and the performance of amplification devices. 5

Prognostic Considerations

  • Bilateral sudden sensorineural hearing loss is associated with markedly poorer outcomes (≈ 29 % recovery in children and lower rates in adults) and should prompt evaluation for systemic etiologies such as meningitis, autoimmune inner‑ear disease, Lyme disease, syphilis, ototoxic medication exposure, or trauma. 3

Immediate Management of Sudden Sensorineural Hearing Loss

Diagnosis and Initial Management

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends urgent formal audiometry within 24-48 hours to confirm sudden sensorineural hearing loss (SSNHL), followed by immediate initiation of systemic corticosteroids if the diagnosis is confirmed, as every day of delay worsens prognosis for hearing recovery 6, 7
  • Perform Weber and Rinne tuning fork tests immediately to differentiate conductive from sensorineural hearing loss, as this fundamentally changes the management pathway 6, 7, 8

Treatment Protocol

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends starting oral prednisone 1 mg/kg/day (maximum 60 mg) as a single daily dose immediately for 7-14 days, followed by taper, for patients with confirmed SSNHL 6, 8
  • Treatment initiated within 2 weeks of symptom onset is associated with better outcomes, but earlier treatment (within 5 days) shows statistically significantly lower rates of unchanged hearing 6

Patient Education and Workup

  • The American Academy of Otolaryngology-Head and Neck Surgery mandates that patients be educated about the natural history of SSNHL, including the fact that 32-65% of cases may recover spontaneously, and the treatment limitations, including the unknown underlying etiology in 85-90% of cases 9
  • Assess for bilateral hearing loss, recurrent episodes, or focal neurologic findings that would suggest stroke, vestibular schwannoma, or other serious pathology, and obtain MRI of internal auditory canals or auditory brainstem response (ABR) to evaluate for retrocochlear pathology 6, 10

Follow-Up and Rehabilitation

  • If incomplete recovery at 2-6 weeks after initial steroid treatment, offer intratympanic steroid perfusion: 4-6 injections of dexamethasone over 2 weeks 6, 8
  • Obtain audiometric evaluation at conclusion of treatment and within 6 months to document final hearing status, and counsel patients with residual hearing loss or tinnitus about audiologic rehabilitation, hearing aids, and assistive listening devices 6, 11, 8

REFERENCES

1

clinical practice guideline: sudden hearing loss (update). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019

2

clinical practice guideline: sudden hearing loss (update) executive summary. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019

3

clinical practice guideline: sudden hearing loss. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012

4

clinical practice guideline: sudden hearing loss. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012

5

clinical practice guideline: sudden hearing loss (update). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019

6

clinical practice guideline: sudden hearing loss. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012

7

Urgent Evaluation and Management of Suspected Tympanic Membrane Perforation [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

Management of Sensorineural Hearing Loss with Pulmonary Stenosis and Pectus Carinatum Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

9

clinical practice guideline: sudden hearing loss. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012

10

clinical practice guideline: sudden hearing loss. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012

11

clinical practice guideline: sudden hearing loss (update). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019